TransMedics Group (TMDX) PT Raised to $80 at Stifel on Q2 Top-line Beat

June 18, 2026 6:54 AM

Stifel analyst Thomas Stephan raised the price target on TransMedics Group (NASDAQ: TMDX) to $80.00 (from $75.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found